首页> 外国专利> POLYGLUTAMIC ACIDS FUNCTIONALIZED BY CATIONIC GROUPS AND HYDROPHOBIC GROUPS AND APPLICATIONS THEREOF, IN PARTICULAR THERAPEUTIC APPLICATIONS THEREOF

POLYGLUTAMIC ACIDS FUNCTIONALIZED BY CATIONIC GROUPS AND HYDROPHOBIC GROUPS AND APPLICATIONS THEREOF, IN PARTICULAR THERAPEUTIC APPLICATIONS THEREOF

机译:被阳离子基团和疏水基团官能化的多聚乙酸及其应用,特别是其在治疗学中的应用

摘要

The disclosure relates to biodegradable materials based on modified polyamino acids that can be used, in particular, for the vectorization of active principle(s) (PA). The disclosure also relates to pharmaceutical, cosmetic, dietetic or phytosanitary compositions based on these polyamino acids. The objective of the invention is to provide a polymer starting material that is capable of being used for the AP vectorization and that makes it possible to optimally satisfy all the specifications required in the case in point: biocompatibility, biodegradability, ability to associate easily with numerous active principles or to dissolve them, and to release these active principles in vivo. The disclosure particularly relates to polyglutamates modified by cationic groups that, if they can be deprotonated, have a pKa greater than or equal to 7, and by hydrophobic groups comprising from 8 to 30 carbon atoms. These polyglutamates modified by cationic groups are capable of being easily and economically converted into particles for the vectorization of active principles, these particles being themselves capable of forming stable aqueous colloidal suspensions. These modified polyglutamates have the advantage of being less viscous than other similar polymers, while retaining an ability to associate proteins such as insulin. Some are soluble in water at acid pH and become insoluble at physiological pH (7.4) and should therefore, during a subcutaneous injection, precipitate at the injection site.
机译:本公开涉及基于修饰的聚氨基酸的可生物降解的材料,其可特别地用于活性成分(PA)的向量化。本发明还涉及基于这些聚氨基酸的药物,化妆品,饮食或植物检疫组合物。发明内容本发明的目的是提供一种聚合物起始材料,其能够用于AP矢量化并且使得可以最佳地满足以下情况下所需的所有规格:生物相容性,生物降解性,易于与多种物质缔合的能力。有效成分或使其溶解,并在体内释放这些有效成分。本公开特别涉及通过阳离子基团改性的聚谷氨酸盐,如果它们可以被去质子化,则pKa大于或等于7,并且通过包含8至30个碳原子的疏水基团改性。这些通过阳离子基团改性的聚谷氨酸盐能够容易且经济地转化为用于活性成分矢量化的颗粒,这些颗粒本身能够形成稳定的水性胶体悬浮液。这些改性的聚谷氨酸盐的优点是比其他类似的聚合物粘度低,同时保留了结合蛋白质如胰岛素的能力。一些在酸性pH下可溶于水,而在生理pH(7.4)下则不溶,因此,在皮下注射过程中,应在注射部位沉淀。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号